Hospira Issues Voluntary Hydromorphone Recall

Hospira, Inc. is recalling one lot of hydromorphone HCl Injection, USP, CII (2 mg/mL) 1 mg/mL vial, in a voluntary move. The reason for the recall is a potential lack of sterility assurance resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

In the event that the affected product is administered to a patient, mild adverse events ranging from fever, chills and malaise, to severe adverse events such as septicemia, bacterial meningitides and wound